| 000 | 01713 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514085401.0 | ||
| 264 | 0 | _c20030930 | |
| 008 | 200309s 0 0 eng d | ||
| 022 | _a0161-6420 | ||
| 024 | 7 |
_a10.1016/S0161-6420(03)00785-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKatz, Joanne | |
| 245 | 0 | 0 |
_aRisks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. _h[electronic resource] |
| 260 |
_bOphthalmology _cSep 2003 |
||
| 300 |
_a1784-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 |
_aCanada _xepidemiology |
| 650 | 0 | 4 | _aCataract Extraction |
| 650 | 0 | 4 |
_aEye Hemorrhage _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xchemically induced |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aThromboembolism _xchemically induced |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 |
_aWarfarin _xtherapeutic use |
| 700 | 1 | _aFeldman, Marc A | |
| 700 | 1 | _aBass, Eric B | |
| 700 | 1 | _aLubomski, Lisa H | |
| 700 | 1 | _aTielsch, James M | |
| 700 | 1 | _aPetty, Brent G | |
| 700 | 1 | _aFleisher, Lee A | |
| 700 | 1 | _aSchein, Oliver D | |
| 773 | 0 |
_tOphthalmology _gvol. 110 _gno. 9 _gp. 1784-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0161-6420(03)00785-1 _zAvailable from publisher's website |
| 999 |
_c12896915 _d12896915 |
||